Birmingham has more bioscience.
A center of medical and scientific excellence, the Greater Birmingham Region has the critical assets, experience and infrastructure to support medical device, drug delivery and drug discovery enterprises from around the world.
With over 82,000 people directly employed in science, health care and pharmaceutical development, the Greater Birmingham Region is the largest bioscience cluster in Alabama. It is a center of world-class research with a highly productive and skilled workforce specializing in drug delivery, formulation science and controlled-release technology.
Currently, more than 150 companies are engaged in different aspects of life science, including representation by the world’s top pharmaceutical companies. The Greater Birmingham Region has recently been designated as a federally recognized TechHub due to our work in biotech.
Bioscience Employers
Talent Pipeline
The future of the bioscience workforce is robust. Over the past five years, 14 life sciences companies have announced nearly 700 jobs and over $80 million in capital investment. During those five years, there has been a 10% increase in the number of bioscience degrees awarded in the region.
The Bioscience Technician Program aims to equip aspiring individuals with the necessary skills and knowledge to pursue fulfilling careers in the biotech industry. Candidates with a high school diploma, proficiency in Microsoft Office and basic math skills are encouraged to apply for this transformative opportunity. The access to top technical talent and industry experts continues to make it a desirable location for companies interested in tapping into premier assets.
University of Alabama at Birmingham
A center of medical and scientific excellence, the University of Alabama at Birmingham continues to see record-breaking levels of extramural research funding, reaching $715 million in FY2022 – a 50% increase over the past five years.
Secured nearly $390 million in NIH funding in FY 2022 and $715 million in total research funding
8th largest public hospital in the nation
Serves over 1.5 million patients annually
Currently conducts 770 active clinical trials and studies
Southern Research
Southern Research, a nonprofit translational research institute specializing in drug and vaccine discovery and development.
Southern Research has created 7 FDA-approved cancer drugs, tested over half of today’s active chemotherapies, and launched a Venture Studio to foster startups for new therapeutic products.
Conducting over $700 million annually in research expenditures from grants in the biomedical sciences, placing Birmingham on par with MSAs such as San Diego, San Francisco, and Philadelphia on a per-capita basis.
They actively seek non-dilutive and equity funding to advance early-stage research into clinical development.
Birmingham has more stories.
Birmingham has
more stories.
Advanced Manufacturing | Economy | 01.10.2024
Primordial Ventures Selects Birmingham For Medical Supplies Production Hub
madeinalabama.com
Economy | Headquarters | 01.10.2024
Brasfield & Gorrie To Expand Birmingham Headquarters To Support 85 New Jobs
madeinalabama.com